
Rising PE Firm Catalio Capital Management to Buy Hedge Fund Healthcor
Up and coming Catalio Capital Management is acquiring HealthCor Management, a healthcare-focused hedge fund founded by veteran investors Art Chen and Joe Healey.
According to STAT News the deal is expected to close in 2023 and is mostly a stock transaction.
Launched in 2005, HealthCor is a value-based investor dedicated to identifying global healthcare and life science equity securities that are mispriced.
Healey and Cohen have an extensive career of investing in the sector and have co-invested for over 20 years as a team.
Catalio Capital is a multi-strategy life sciences investment firm that manages more than $1bn in assets across its private equity, private credit and public equities strategies.
The news follows Catalio’s close of its debut special situations fund in November – Catalio Credit Opportunities Fund I, an $85 million fund that will invest in small and mid-sized life sciences companies at various stages of growth.
The fund is the second investment vehicle that Catalio has raised in 2022, following the close of Catalio Nexus Fund III, the firm’s third flagship private equity fund, earlier this year.